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 Over 1500 different lipids have been reported in human plasma at the sum 
composition level. Yet the number of unique lipids present is surely higher, once isomeric 
contributions from double bond location(s) and fatty acyl regiochemistry are considered. In 
order to resolve this ambiguity, herein we describe the incorporation of ozone-induced 
dissociation (OzID) into data-independent shotgun lipidomics workflows on a high-resolution 
hybrid quadrupole-Orbitrap platform. In this configuration, [M+Na]
+
 ions generated by 
electrospray ionization of a plasma lipid extract were transmitted through the quadrupole in 1 
Da segments. Reaction of mass-selected lipid ions with ozone in the octopole collision cell 
yielded diagnostic ions for each double bond position. The increased ozone concentration in 
this region significantly improved ozonolysis efficiency compared to prior implementations 
on linear ion-trap devices. This advancement translates into increased lipidome coverage, and 
improvements in duty cycle for data-independent MS/MS analysis using shotgun workflows. 
Grouping all precursor ions with a common OzID neutral loss enables straightforward 
classification of the lipidome by unsaturation position (with respect to the methyl terminus). 
2-dimensional maps obtained from this analysis provide a powerful visualization of 
structurally-related lipids and lipid isomer families within plasma. Global profiling of lipid 
unsaturation in plasma extracts reveals that most unsaturated lipids are present as isomeric 
mixtures. These new insights provide a unique picture of underlying metabolism that could in 
the future provide novel indicators of health and disease. 
 





 Human blood plasma is a tightly regulated biological fluid, rich in lipids and 
metabolites, that is readily available in clinical settings. The composition of the plasma 
lipidome can provide a snapshot of human metabolism.[1] Moreover, changes in plasma lipid 
concentrations have been widely studied in biomarker discovery for various pathologies, 
including Alzheimer’s disease,[2] prostate cancer,[3] metabolic dysfunction,[4] and 
cardiovascular disease,[5] among others.[6]  
 The unparalleled sensitivity and specificity of contemporary mass spectrometers (and 
associated developments in bioinformatics) has led to mass spectrometry-based methods 
becoming the analytical tool of choice for characterizing complex lipid extracts from 
biological systems; including human blood plasma. Plasma lipid extracts have been analysed 
by high-resolution ‘top-down’ shotgun lipidomics,[7, 8] or in conjunction with prior 
fractionation by chromatographic and/or ion-mobility separations to resolve lipid classes,[9-
11] or unique lipids within a class.[12] These collective efforts have driven the development 
of certified standard reference materials (e.g., SRM1950: metabolites in human plasma, 





, Avanti Polar Lipids) that mimic human plasma, to 
facilitate more accurate quantitation of plasma lipids. Despite these achievements, the 
challenge of fully elucidating the human plasma lipidome has been clearly laid out by an 
inter-laboratory study using SRM1950.[14] Among the 1527 different lipids identified at the 
sum composition level (number of carbons and degree of unsaturation), consensus between 5 
or more laboratories could only be reached for the concentration of 339 lipid species. 
Unsurprisingly, there is a continued impetus to develop guidelines in order to standardize 
lipidomics approaches in order to bridge the gap between the analytical laboratory and 
clinical diagnostics.[15-17]  
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 Yet even this startling result does not capture the full extent of the task confronting 
the lipidomics community. Assigning a lipid only at the sum composition level overlooks 
more detailed descriptions of molecular structure, referred to by Koelmel and co-workers as 
the structural resolution in lipid identification.[18] The inability to resolve isomeric species 
leads to a significant under-estimation of the diversity of unique molecular species within the 
lipidome,[19, 20] and raises the possibility that identified biomarkers are not unique 
molecules, but instead represent a mixture of isomers. Isomeric overlap can arise in 
glycerolipids and glycerophospholipids from the presence of multiple species with a common 
lipid class and sum composition but varying in the composition and relative position (sn-
position) of fatty acyl chains on the glycerol backbone. While acyl chain composition can be 
determined by tandem mass spectrometry (e.g., PC 16:0_20:1 is resolved from PC 
18:0_18:1), regioisomers differing only in the position of the chains (e.g., PC 16:0/20:1 and 
PC 20:1/16:0) are typically resolved by: exhaustive chromatographic or ion-mobility 
separations;[21-23] combinations of CID with ion-molecule reactions;[24, 25] or carefully 
calibrated CID-based methods.[26-29] Zacek and co-workers used a negative ion MS/MS-
based approach to quantify isomeric phosphatidylcholines (PCs) in human plasma.[30] This 
analysis extended the list of 22 PCs identified by sum composition (e.g., PC 36:1) to 41 
species with defined composition of the constituent fatty acids. Moreover, both possible 
regioisomers were found to be present in 35 of these 41 PCs. Taken together, these data 
contribute an almost four-fold increase in the number of PCs assigned in human plasma (see 
Figure 1). Although this regioisomer-specific analysis was conducted only on PCs, it is not 
difficult to envisage that such diversity would be replicated across all glycerolipid and 
glycerophospholipid classes. 
 The critical structural detail that remains beyond the reach of conventional MS/MS-
based lipidomics is the assignment of double bond position and stereochemistry within a fatty 
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acyl chain, which would complete the description of the ‘structurally defined molecular 
lipid’.[31] Double bond position has a significant impact on the physical properties of 
macromolecular lipid assemblies.[32-34] Moreover, changes in unsaturation position within 
the cellular lipidome (due to dysregulation of desaturase enzymes) have been implicated in 
various pathologies including cancer.[35, 36] However, double bond-specific fragmentation 
is typically not observed with low-energy CID, or the diagnostic ions are present only in 
minor abundance in complex spectra.[37] Resolution of lipid isomers varying only by double 
bond position has been successfully demonstrated by ion-mobility spectrometry,[38-40] the 
Paternò-Büchi reaction,[41] UV photodissociation,[42, 43] electron impact excitation of ions 
from organics,[44] or by chemical derivatization prior to tandem mass spectrometry 
analysis.[45] While some attempts have been made to apply these techniques to profiling 
unsaturation in free fatty acids from human plasma,[46, 47] only recently has attention turned 
to unsaturation within complex plasma lipids.[48] Ozone-induced dissociation (OzID) 
exploits the chemical reaction between ozone and mass-selected lipid ions, thereby 
generating product ions with predictable neutral losses depending on the position(s) of 
unsaturation.[49, 50] In this work, OzID is implemented on a high-resolution hybrid 
quadrupole-Orbitrap mass spectrometer (Q Exactive
TM
 HF) in order to profile unsaturation in 
multiple complex lipid classes extracted from human plasma using a data-independent 








Figure 1: Hierarchical description of the number of unique PC lipids in human plasma. 
Experimental data taken from Zacek et al.[30] The outer circle represents a theoretical 
maximum obtained from searching the 22 reported PC sum compositions against the Lipid 





 Optima LC-MS grade water, methanol, and HPLC grade methyl tert-butyl ether 
(MTBE) were obtained from Fisher Scientific (Schwerte, Germany) and used as received. 
Sodium acetate (LC-MS grade) and citrated human blood plasma were purchased from 
Sigma-Aldrich (Munich, Germany). 
Lipid extraction and sample preparation 
 Lipids were extracted from 40 µL aliquots of human plasma following an MTBE-
based lipid extraction protocol, as previously described.[51] MTBE extracts were evaporated 
to dryness and subsequently re-dissolved in 800 µL methanol containing 0.1 mM sodium 
acetate, as [M+Na]
+





 precursor ions.[38] 
Mass spectrometry 
 Mass spectra were acquired in positive ion mode using a heated electrospray 
ionization source on a high-resolution Q Exactive
TM
 HF hybrid quadrupole Orbitrap mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany). The instrument was modified as 
shown in Supporting Information Figure S1 to facilitate the introduction of ozone into the 
collision cell normally filled with nitrogen for higher-energy collisional dissociation 
(HCD).[52] As shown in Supporting Information Figure S2, this configuration affords a 
significant increase in OzID product ion abundances compared to implementation in a linear 
ion-trap. Ozone (ca. 13% w/w O2) was produced online by an ozone generator (HC-30, 
Ozone Solutions, Hull, IA) and connected to a stainless-steel union tee with ozone-resistant 
1/4” Teflon tubing. The ozone was supplied to the instrument via a PEEKsil
TM
 restrictor (50 
μm (i.d.) x 100 mm) to control the flow rate of gas entering the collision cell. The HCD gas 
supply line was interrupted by insertion of a 3-way ball valve, which enables switching 
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between the output from the PEEKsil
TM
 restriction and the native nitrogen supply. 
Downstream from the union tee, ozone is destroyed by a catalytic destruct (IN USA, 
Norwood, MA) and ultimately exhausted from the laboratory. Ozone monitors (2B 
Technologies, Boulder, CO) recorded the ozone concentration within the closed system 
upstream from the union tee and in the ambient laboratory air. 
 OzID spectra were acquired in a data-independent workflow from m/z 650 - 950 in 1 
Da increments. For these experiments, the mass resolution was set to 240,000 (at m/z 200), 
the isolation window 1.4 Da, and the collision energy set to the minimum value (10 arbitrary 
units). Mass-selected precursor ions were exposed to ozone for 0.5 s, preceding mass analysis 
in the Orbitrap. Ten transients were averaged prior to the Fourier transform. Post-acquisition, 
data were visualized and analyzed using Xcalibur Qual Browser (version 3.0.63, Thermo 
Fisher Scientific). Reconstructed unsaturation profiles from ions exhibiting a common OzID 
neutral loss are extracted with a tolerance of 0.1 Da.  
Nomenclature 
 Lipid nomenclature is based on literature recommendations.[53, 54] For example, the 
shorthand notation PC 34:1 represents a phosphatidylcholine lipid containing 34 carbons and 
a single double bond within its fatty acyl chains. Unsaturation in a fatty acyl chain is defined 
with respect to the alkyl terminus by (n-x), where x is the number of carbons from the methyl 
group to the double bond (e.g., PC 34:1(n-9)). Note that in this representation, neither the 
identity of the fatty acid carrying the double bond, nor the fatty acid position on the glycerol 
backbone (sn-position) are explicitly identified. When the fatty acid identities are known, the 
underscore separator is used (e.g., PC 16:0_18:1(n-9)). Explicit identification of both the fatty 
acid identity and sn-position is denoted by a slash (e.g., PC 16:0/18:1(n-9)). Double bond 




Results and Discussion 
 Previous quantitative studies have determined that the most abundant lipid classes in 
the plasma lipidome are cholesterol and cholesteryl esters (CE), phosphatidylcholines (PC), 
phosphatidylethanolamines (PE), triacylglycerols (TG) and sphingomyelin (SM).[9, 14] 
Aside from cholesterol, each class is comprised of at least 18 different sum compositions. 
The aim of the present work is not to recapitulate these studies, but to explore the diversity of 
isomeric structures within a single sum composition assignment. OzID spectra were acquired 
across the range m/z 650 - 950 in 1 Da steps for [M+Na]
+
 ions generated by direct infusion 
ESI of a plasma lipid extract. The complete dataset (obtained in under 40 minutes) was 
subsequently interrogated to explore lipid unsaturation and isomeric diversity in plasma. 
OzID spectra were obtained for unsaturated lipid species at or above 1 nmol/mL (e.g., Cer 
d18:1/24:1(n-9),[9] see Supporting Information Figure S3). 
Unsaturation in plasma cholesteryl esters 
 One of the most abundant lipids in human plasma is CE 18:2 (1.8 µmol/mL),[9, 14] 
that is, the cholesteryl ester of a fatty acid with 18 carbons and 2 double bonds. Moreover, CE 
18:2 in plasma has been identified as a potential biomarker for squamous cell lung 
carcinoma.[55] As shown in Figure 2b, ozonolysis of sodiated CE 18:2 ions (m/z 671.58) in 
the octopole collision cell for 0.5 s resulted in almost complete reaction of the precursor ion. 
Ozonolysis yielded an abundant [M+Na+16]
+
 product ion (m/z 687.57), assigned to the 
formation of an epoxide on the tetracyclic sterol ring system.[56] Reaction of the alkene(s) on 
the fatty acyl chain with ozone can arise from either the  [M+Na+16]
+
 ion or an [M+Na+48]
+
 
product ion resulting from ring-opening.[56] As such, 2 pairs of OzID product ions (offset by 
32 Da) associated with each double bond of the 18:2 fatty acyl can be assigned according to 
predictable ozonolysis transitions shown in Table 2, consistent with the n-6 and n-9 double 
bonds of linoleic acid. Thus the ion at m/z 671.58 can be confidently assigned as exclusively 
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comprising CE 18:2(n-6, n-9), as reported previously.[57] Similarly, the OzID spectrum in 
Figure 2d shows that CE 20:4 (m/z 695.57) is uniquely cholesteryl arachidonate (i.e., CE 
20:4(n-6, n-9, n-12, n-15)). Conversely, the OzID spectra shown in Figure 2a and 2c 
demonstrate that CE 18:1 (m/z 673.59) and CE 18:3 (m/z 669.56) have contributions from 
multiple isomers. Neutral losses of 110.15 Da and 94.15 Da (see Table 1) from either the 
[M+Na+16]
+
 ion or [M+Na+48]
+
 ion indicate that the predominant isomer contributing to m/z 
673.59 is CE 18:1(n-9). However, aldehyde product ions with a neutral loss of 82.11 Da and 
124.16 Da are also observed, at lower abundance, indicative of CE 18:1(n-7) and CE 18:1(n-
10). Differing rates of ozonolysis as a function of double bond position[58] mean that relative 
quantitation of these isomers is not possible without reference to pure standards, however, a 
molar ratio of 1:12 has previously been reported for the CE 18:1(n-7) and CE 18:1(n-9) 
isomers, which is consistent with these data.[57] Importantly, although all precursor ions of 
m/z 673.6 ± 0.7 Da react with ozone in the octopole collision cell in the configuration 
presented here, subsequent high resolution mass analysis in the Orbitrap enables the 
discrimination of isobaric precursor ions (and their reaction products), such that the [M+2] 
isotopic peak of CE 18:2 is resolved from CE 18:1 (Δ = 7.5 mDa, Rs ~ 90,000). 
Trends in unsaturation across the plasma lipidome 
 Spectral acquisition in a data-independent workflow enables the compilation of all 
OzID spectra across the target m/z range into a heat map, providing a global snapshot of 
unsaturation in the plasma lipidome. In this representation, as shown in Figure 3, each 
vertical slice is an individual OzID spectrum, with all precursor ions falling on a diagonal 
line. Regardless of their class, all lipid ions with a common position of unsaturation (with 
respect to the methyl terminus of the fatty acyl) also fall on parallel diagonal lines, as a 




Figure 2: OzID spectra obtained for (a) CE 18:1 (m/z 673.59); (b) CE 18:2 (m/z 671.57); (c) 
CE 18:3 (m/z 669.56); and (d) CE 20:4 (m/z 695.58). The precursor ion in each spectrum is 
indicated by a star while [M+Na+16]
+
 product ions are denoted by closed circles. For clarity, 
[M+Na+48]
+
 product ions are not shown. OzID product ions indicative of the positions of 
unsaturation are colour-coded and indicated with coloured brackets. 
 
The data plotted in Figure 3 can be used to readily identify the major complex lipids 
containing fatty acyls with a specific position of unsaturation. Integrating along each diagonal 
line yields a profile of all lipids containing a specific position of unsaturation, in the form of a 
reconstructed spectrum of all precursor ions exhibiting a common neutral loss, as shown in 
Figure 4. For example, the reconstructed neutral loss representation in Figure 4e shows that 
the nutritionally essential n-3 fatty acyls (identified by a common 26.05 Da loss) are located 
predominantly in triacylglycerols (TGs) of 50-54 carbons but also identifies PC 36:5 and PC 
38:6 as omega-3 fatty acid carriers. Similarly, the profiles of n-9, n-7, and n-6 double bonds 
(Figure 4a-c) are also dominated by the highly abundant TGs of 50-52 carbons and, to a 
lesser extent, PCs of 34-38 carbons. While it must be noted that the ordinate of these 
reconstructed spectra reflects the raw abundance of OzID product ions (a function of both the 
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precursor ion abundance and ozonolysis reaction rate) these reconstructed neutral loss spectra 
afford a rich, qualitative snapshot of unsaturation across the extract. 
 
Figure 3: The unsaturation profile of complex plasma lipids from a data-independent OzID 
workflow obtained by plotting all precursor ions against product ions. Ions corresponding to 
all lipid carriers of n-3, n-6 and n-9 double bonds are contained in the zones bordered by 
highlighted diagonal lines. 
  
Compared to C=C double bonds within fatty acyl chains, the trans n-14 double bond 
within a sphingolipid long-chain base is relatively unreactive toward ozone.[59] Thus, a 
neutral loss of 180.22 Da – diagnostic for an n-14 alkene – does not yield a useful profile of 
sphingosine-containing lipids. As shown in Figure 4d however, a neutral loss of 40.07 Da 
during ozonolysis (indicative of an n-4 double bond) is exclusive to sphingomyelins with at 
least 2 sites of unsaturation. This hypothesis is consistent with the presence of an (n-4, n-14)-
sphingadiene as the long-chain sphingoid base,[60] although it is feasible that the n-4 double 
bond may instead be on the fatty acyl. For example, SM d34:2 in human plasma consists of 
85% SM d18:2/16:0, whereas only 29% of SM d42:2 carries a sphingadiene motif, as 
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determined by MS/MS in negative ion mode.[9] The OzID spectrum acquired from the [SM 
d34:2 + Na]
+
 ion (m/z 723.54) features abundant product ions assigned to the n-4 double bond 
position. By contrast, ozonolysis of SM d42:2 (m/z 835.67) yields product ions diagnostic for 
both the n-4 and n-9 positions. The abundance of the latter ions are greater than the former, 
consistent with the presence of SM d18:1/24:1(n-9) as the major isomer, and SM d18:2(n-4, 
n-14)/24:0 as the minor contributor (see Supporting Information, Figure S4). 
 
High resolution MS with OzID resolves isobaric and isomeric lipids 
 Plasmanyl-, and plasmenyl- (i.e., plasmalogen) ether lipids are isomeric species that 
are not typically resolved by chromatography or low-energy CID, although selective 
chemical derivatization of the plasmalogen double bond has proven successful.[61] Previous 
studies of human plasma have grouped isomeric alkyl ether and vinyl ether lipids (with the 
same total number of double bonds) together as single species.[9] Plasmalogens are 
differentiated from their alkyl ether counterparts by the rapid reaction of the electron-rich 
vinyl ether with ozone, resulting in a neutral loss of 194.24 Da (for P-16:0) or 222.27 Da (for 
P-18:0).[62] Figure 5 highlights that the major PC plasmalogens in human plasma contain 
32-38 carbons, generally partnered by a polyunsaturated fatty acid (PUFA). For example, the 
largest peak identified for both P-16:0 (Figure 5a) and P-18:0 (Figure 5b) species contains a 
20:4 fatty acid. Note that the relative abundances obtained from these profiles differ from the 
total ether PC lipid profile previously reported.[9, 14] These data confirm that plasmalogens 
exhibit a unique profile that is concealed in measurements that do not resolve these species 
from isomeric plasmanyl alkyl ether lipids. Moreover, from these data it is clear that 
biomarkers identified only at the sum composition level can actually be isomeric mixtures. 
For example, plasma PC O-38:5 – proposed as a plasma biomarker for prostate cancer[3] – is 




Figure 4: Unsaturation profiles reconstructed from ions exhibiting a common neutral loss 
(indicated in parentheses). Cholesterol esters are not shown in these profiles due to additional 
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reaction of the sterol headgroup with ozone. Where a lipid class contains multiple species 
with the same number of carbons, the degree of unsaturation is denoted by X (X = 0-9). 
 
Figure 5: Compiling all precursor ions exhibiting a common neutral loss characteristic for: 
(a) n-15 or (b) n-17 double bonds generates a profile of all plasmalogens. 
  
High-resolution mass analysers are beneficial for resolving isobaric lipid ions in 
complex samples.[63] Highlighting the utility of applying OzID on an Orbitrap mass 
spectrometer, ether-linked PCs are differentiated from isobaric dialkyl PEs (with 2 additional 
carbons in the fatty acyls) that differ in mass by approximately 38 mDa (Rs ~20,000). As the 
neutral loss is consistent for all double bonds at the same (n-x) position, it follows that 
product ions resulting from ozonolysis will be similarly resolved. The OzID spectrum shown 
in Figure 6 demonstrates that both PC O-34:1 (m/z 768.59) and PE 36:1 (m/z 768.55) carry n-
9 double bonds. Moreover, the absence of product ions corresponding to n-15 or n-17 double 
bonds (see Figure 5) confirms that PC O-34:1 is comprised exclusively of plasmanyl ether 




Figure 6: Identification of n-9 double bonds in isobaric PC O-34:1 and PE 36:1 lipids 
Towards identification of structurally-defined lipids  
 Based on these data alone, it must be emphasised that the position of unsaturation 
cannot be localized to a specific fatty acyl moiety within a complex lipid. For example, 
identification of an n-9 double bond from the ozonolysis of PC 34:1 is insufficient to 
distinguish isomers that vary in the composition of fatty acyl chains (e.g., PC 16:0/18:1(n-9), 
PC 18:0/16:1(n-9)) and relative sn-position (e.g., PC 18:1(n-9)/16:0, PC 16:0/18:1(n-9)). As 
demonstrated above for sphingomyelins, further insight can be obtained by combining DIA-
OzID data with results from MS/MS experiments that resolve such ambiguities. For example, 
the major isomer of PC 34:1 in human plasma is PC 16:0/18:1 (89%), followed by the 
alternate regioisomer PC 18:1/16:0 (11%).[30] As shown in Figure 7a, ozonolysis of sodiated 
PC 34:1 ions (m/z 782.57) yields pairs of product ions assigned to the n-9 (major) or n-7 
(minor) double bonds of a monounsaturated fatty acid. In the absence of PC 18:0_16:1 or 
other fatty acid combinations, these double bonds can be uniquely assigned to 2 different 
isomers of an 18:1 fatty acyl. Comprising 2 different regioisomers and 2 double bond 
positions, PC 34:1 is composed of up to 4 distinct isomers, namely PC 16:0/18:1(n-7), PC 
16:0/18:1(n-9), PC 18:1(n-7)/16:0, and/or PC 18:1(n-9)/16:0, consistent with recent analysis 
by Zhang and co-workers.[48] . Further MS
n
 interrogation of the precursor ion using a top-
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down combination of CID and OzID on an ion trap mass spectrometer would be required to 
determine whether a specific double bond position is selectively partitioned to the 18:1 fatty 
acyl at the sn-1 or sn-2 position, and unambiguously assign the lipid structure.[25] Similarly, 
PC 34:2 in human plasma is comprised of predominantly PC 16:0/18:2 and its regioisomer 
PC 18:2/16:0.[30] As shown in Figure 7b, the OzID spectrum of PC 34:2 features pairs of 
product ions assigned to the n-6 and n-9 double bonds of a PUFA, consistent with linoleic 
acid. Also observed in the OzID spectrum are product ions assigned to a monounsaturated FA 
with  a double bond in either the n-7 and n-9 position, consistent with the presence of PC 
16:1_18:1 in human plasma.[48, 64]  
 
Figure 7: Ozone induced-dissociation mass spectra obtained for (a) PC 34:1 (m/z 782.57); (b) 
PC 34:2 (m/z 780.57). Ozonolysis of phosphatidylcholines identifies multiple double bond 





 The array of lipids found in human plasma is remarkably diverse in terms of structure 
and concentration, posing a significant analytical challenge to the complete quantitative 
elucidation of the lipidome. Even with the additional dimension of MS/MS, most mass 
spectrometry-based methods identify plasma lipids only at the sum composition or molecular 
lipid level, thus the complexity of the plasma lipidome is systematically understated. In this 
work, ozonolysis was implemented as part of a data-independent acquisition workflow on a 
high-resolution mass spectrometer in order to resolve this complication by profiling 
unsaturation in human plasma lipids across a wide dynamic range down to the low nmol/mL 
level. Regardless of lipid class, fatty acyls with a common position of unsaturation relative to 
the methyl terminus can be classified by a characteristic neutral loss resulting from 
ozonolysis of the alkene. This enables the post-acquisition generation of pseudo neutral loss 
profiles for a given double bond position in monounsaturated and polyunsaturated lipids. 
Using this approach, plasmalogens are readily distinguished from isomeric plasmanyl ether 
lipids and isobaric interferences by the presence of the vinyl ether double bond. 
 Qualitatively, the predominant double bond positions within fatty acyls are consistent 
across the major lipid classes. Previous studies have shown that the distribution of carbon-
carbon double bond locations within fatty acyl chains are tightly conserved between free fatty 
acids and cholesterol esters within a common plasma sample.[47, 57] The conservation of 
double bond profile between different lipid classes confirms their common origins in lipid 
biosynthesis. More broadly, the data obtained here represent a comprehensive archive of 
unsaturation in the human plasma lipidome and will be a valuable resource to interrogate for 
unresolved isomers as new lipid biomarkers are identified. Moreover, this profile may be 
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Associated Content 
A comparison of OzID efficiency in an octopole collision cell and a linear ion trap is included 
as Supporting Information, alongside example OzID spectra for Cer d42:2, SM d34:2, SM 
d42:2, and PC O-38:5. An archive of OzID spectral data acquired in this study is freely 





1. Quehenberger, O., Dennis, E.A.: The Human Plasma Lipidome. New Engl. J. Med. 
365, 1812-1823 (2011) 
2. Mapstone, M., Cheema, A.K., Fiandaca, M.S., Zhong, X., Mhyre, T.R., MacArthur, 
L.H., Hall, W.J., Fisher, S.G., Peterson, D.R., Haley, J.M., Nazar, M.D., Rich, S.A., 
Berlau, D.J., Peltz, C.B., Tan, M.T., Kawas, C.H., Federoff, H.J.: Plasma 
phospholipids identify antecedent memory impairment in older adults. Nat. Med. 20, 
415-418 (2014) 
3. Lin, H.-M., Mahon, K.L., Weir, J.M., Mundra, P.A., Spielman, C., Briscoe, K., 
Gurney, H., Mallesara, G., Marx, G., Stockler, M.R., Consortium, P., Parton, R.G., 
Hoy, A.J., Daly, R.J., Meikle, P.J., Horvath, L.G.: A distinct plasma lipid signature 
associated with poor prognosis in castration-resistant prostate cancer. Int. J. Cancer. 
141, 2112-2120 (2017) 
4. Mousa, A., Naderpoor, N., Mellett, N., Wilson, K., Plebanski, M., Meikle, P.J., de 
Courten, B.: Lipidomic profiling reveals early-stage metabolic dysfunction in 
overweight or obese humans. Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids. 1864, 
335-343 (2019) 
5. Mundra, P.A., Barlow, C.K., Nestel, P.J., Barnes, E.H., Kirby, A., Thompson, P., 
Sullivan, D.R., Alshehry, Z.H., Mellett, N.A., Huynh, K., Jayawardana, K.S., Giles, 
C., McConville, M.J., Zoungas, S., Hillis, G.S., Chalmers, J., Woodward, M., Wong, 
G., Kingwell, B.A., Simes, J., Tonkin, A.M., Meikle, P.J., Investigators, L.S.: Large-
scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in 
secondary prevention. JCI Insight. 3, e121326 (2018) 
6. Vvedenskaya, O., Wang, Y., Ackerman, J.M., Knittelfelder, O., Shevchenko, A.: 
Analytical challenges in human plasma lipidomics: A winding path towards the truth. 
TrAC, Trends Anal. Chem., https://doi.org/10.1016/j.trac.2018.1010.1013 (2018) 
7. Schuhmann, K., Almeida, R., Baumert, M., Herzog, R., Bornstein, S.R., Shevchenko, 
A.: Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching 
between acquisition polarity modes. J. Mass Spectrom. 47, 96-104 (2012) 
8. Gallego, S.F., Højlund, K., Ejsing, C.S.: Easy, Fast, and Reproducible Quantification 
of Cholesterol and Other Lipids in Human Plasma by Combined High Resolution 
MSX and FTMS Analysis. J. Am. Soc. Mass Spectrom. 29, 34-41 (2018) 
9. Quehenberger, O., Armando, A.M., Brown, A.H., Milne, S.B., Myers, D.S., Merrill, 
A.H., Bandyopadhyay, S., Jones, K.N., Kelly, S., Shaner, R.L., Sullards, C.M., Wang, 
E., Murphy, R.C., Barkley, R.M., Leiker, T.J., Raetz, C.R.H., Guan, Z., Laird, G.M., 
Six, D.A., Russell, D.W., McDonald, J.G., Subramaniam, S., Fahy, E., Dennis, E.A.: 
Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 
3299-3305 (2010) 
10. Baglai, A., Gargano, A.F.G., Jordens, J., Mengerink, Y., Honing, M., van der Wal, S., 
Schoenmakers, P.J.: Comprehensive lipidomic analysis of human plasma using 
multidimensional liquid- and gas-phase separations: Two-dimensional liquid 
chromatography–mass spectrometry vs. liquid chromatography–trapped-ion-
mobility–mass spectrometry. J. Chromatogr. A. 1530, 90-103 (2017) 
11. Rampler, E., Criscuolo, A., Zeller, M., El Abiead, Y., Schoeny, H., Hermann, G., 
Sokol, E., Cook, K., Peake, D.A., Delanghe, B., Koellensperger, G.: A Novel 
Lipidomics Workflow for Improved Human Plasma Identification and Quantification 




12. Christinat, N., Morin-Rivron, D., Masoodi, M.: High-Throughput Quantitative 
Lipidomics Analysis of Nonesterified Fatty Acids in Human Plasma. J. Proteome Res. 
15, 2228-2235 (2016) 
13. Phinney, K.W., Ballihaut, G., Bedner, M., Benford, B.S., Camara, J.E., Christopher, 
S.J., Davis, W.C., Dodder, N.G., Eppe, G., Lang, B.E., Long, S.E., Lowenthal, M.S., 
McGaw, E.A., Murphy, K.E., Nelson, B.C., Prendergast, J.L., Reiner, J.L., Rimmer, 
C.A., Sander, L.C., Schantz, M.M., Sharpless, K.E., Sniegoski, L.T., Tai, S.S.C., 
Thomas, J.B., Vetter, T.W., Welch, M.J., Wise, S.A., Wood, L.J., Guthrie, W.F., 
Hagwood, C.R., Leigh, S.D., Yen, J.H., Zhang, N.-F., Chaudhary-Webb, M., Chen, 
H., Fazili, Z., LaVoie, D.J., McCoy, L.F., Momin, S.S., Paladugula, N., Pendergrast, 
E.C., Pfeiffer, C.M., Powers, C.D., Rabinowitz, D., Rybak, M.E., Schleicher, R.L., 
Toombs, B.M.H., Xu, M., Zhang, M., Castle, A.L.: Development of a Standard 
Reference Material for Metabolomics Research. Anal. Chem. 85, 11732-11738 (2013) 
14. Bowden, J.A., Heckert, A., Ulmer, C.Z., Jones, C.M., Koelmel, J.P., Abdullah, L., 
Ahonen, L., Alnouti, Y., Armando, A.M., Asara, J.M., Bamba, T., Barr, J.R., 
Bergquist, J., Borchers, C.H., Brandsma, J., Breitkopf, S.B., Cajka, T., Cazenave-
Gassiot, A., Checa, A., Cinel, M.A., Colas, R.A., Cremers, S., Dennis, E.A., Evans, 
J.E., Fauland, A., Fiehn, O., Gardner, M.S., Garrett, T.J., Gotlinger, K.H., Han, J., 
Huang, Y., Neo, A.H., Hyötyläinen, T., Izumi, Y., Jiang, H., Jiang, H., Jiang, J., 
Kachman, M., Kiyonami, R., Klavins, K., Klose, C., Köfeler, H.C., Kolmert, J., Koal, 
T., Koster, G., Kuklenyik, Z., Kurland, I.J., Leadley, M., Lin, K., Maddipati, K.R., 
McDougall, D., Meikle, P.J., Mellett, N.A., Monnin, C., Moseley, M.A., 
Nandakumar, R., Oresic, M., Patterson, R., Peake, D., Pierce, J.S., Post, M., Postle, 
A.D., Pugh, R., Qiu, Y., Quehenberger, O., Ramrup, P., Rees, J., Rembiesa, B., 
Reynaud, D., Roth, M.R., Sales, S., Schuhmann, K., Schwartzman, M.L., Serhan, 
C.N., Shevchenko, A., Somerville, S.E., St. John-Williams, L., Surma, M.A., Takeda, 
H., Thakare, R., Thompson, J.W., Torta, F., Triebl, A., Trötzmüller, M., 
Ubhayasekera, S.J.K., Vuckovic, D., Weir, J.M., Welti, R., Wenk, M.R., Wheelock, 
C.E., Yao, L., Yuan, M., Zhao, X.H., Zhou, S.: Harmonizing lipidomics: NIST 
interlaboratory comparison exercise for lipidomics using SRM 1950–Metabolites in 
Frozen Human Plasma. J. Lipid Res. 58, 2275-2288 (2017) 
15. Burla, B., Arita, M., Arita, M., Bendt, A.K., Cazenave-Gassiot, A., Dennis, E.A., 
Ekroos, K., Han, X., Ikeda, K., Liebisch, G., Lin, M.K., Loh, T.P., Meikle, P.J., 
Orešič, M., Quehenberger, O., Shevchenko, A., Torta, F., Wakelam, M.J.O., 
Wheelock, C.E., Wenk, M.R.: MS-based lipidomics of human blood plasma: a 
community-initiated position paper to develop accepted guidelines. J. Lipid Res. 59, 
2001-2017 (2018) 
16. Bowden, J.A., Ulmer, C.Z., Jones, C.M., Koelmel, J.P., Yost, R.A.: NIST lipidomics 
workflow questionnaire: an assessment of community-wide methodologies and 
perspectives. Metabolomics. 14, 53 (2018) 
17. Liebisch, G., Ekroos, K., Hermansson, M., Ejsing, C.S.: Reporting of lipidomics data 
should be standardized. Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids. 1862, 747-
751 (2017) 
18. Koelmel, J.P., Ulmer, C.Z., Jones, C.M., Yost, R.A., Bowden, J.A.: Common cases of 
improper lipid annotation using high-resolution tandem mass spectrometry data and 
corresponding limitations in biological interpretation. Biochim. Biophys. Acta, Mol. 
Cell. Biol. Lipids. 1862, 766-770 (2017) 
19. Hancock, S.E., Poad, B.L.J., Batarseh, A., Abbott, S.K., Mitchell, T.W.: Advances 
and unresolved challenges in the structural characterization of isomeric lipids. Anal. 
Biochem. 524, 45-55 (2017) 
22 
 
20. Shevchenko, A., Simons, K.: Lipidomics: coming to grips with lipid diversity. Nat. 
Rev. Mol. Cell Biol. 11, 593-598 (2010) 
21. Wozny, K., Lehmann, W.D., Wozny, M., Akbulut, B.S., Brügger, B.: A method for 
the quantitative determination of glycerophospholipid regioisomers by UPLC-ESI-
MS/MS. Anal. Bioanal. Chem. 411, 915-924 (2019) 
22. Kozlowski, R.L., Mitchell, T.W., Blanksby, S.J.: Separation and identification of 
phosphatidylcholine regioisomers by combining liquid chromatography with a fusion 
of collision-and ozone-induced dissociation. Eur. J. Mass Spectrom. 21, 191-200 
(2015) 
23. Maccarone, A.T., Duldig, J., Mitchell, T.W., Blanksby, S.J., Duchoslav, E., 
Campbell, J.L.: Characterization of acyl chain position in unsaturated 
phosphatidylcholines using differential mobility-mass spectrometry. J. Lipid Res. 55, 
1668-1677 (2014) 
24. Marshall, D.L., Pham, H.T., Bhujel, M., Chin, J.S.R., Yew, J.Y., Mori, K., Mitchell, 
T.W., Blanksby, S.J.: Sequential collision- and ozone-induced dissociation enables 
assignment of relative acyl chain position in triacylglycerols. Anal. Chem. 88, 2685-
2692 (2016) 
25. Pham, H.T., Maccarone, A.T., Thomas, M.C., Campbell, J.L., Mitchell, T.W., 
Blanksby, S.J.: Structural characterization of glycerophospholipids by combinations 
of ozone- and collision-induced dissociation mass spectrometry: The next step 
towards "top-down" lipidomics. Analyst. 139, 204-214 (2014) 
26. Leskinen, H.M., Suomela, J.-P., Kallio, H.P.: Quantification of triacylglycerol 
regioisomers by ultra-high-performance liquid chromatography and ammonia 
negative ion atmospheric pressure chemical ionization tandem mass spectrometry. 
Rapid Commun. Mass Spectrom. 24, 1-5 (2010) 
27. Řezanka, T., Pádrová, K., Sigler, K.: Regioisomeric and enantiomeric analysis of 
triacylglycerols. Anal. Biochem. 524, 3-12 (2017) 
28. Ekroos, K., Ejsing, C.S., Bahr, U., Karas, M., Simons, K., Shevchenko, A.: Charting 
molecular composition of phosphatidylcholines by fatty acid scanning and ion trap 
MS3 fragmentation. J. Lipid Res. 44, 2181-2192 (2003) 
29. Han, X., Gross, R.W.: Structural determination of picomole amounts of phospholipids 
via electrospray ionization tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 6, 
1202-1210 (1995) 
30. Zacek, P., Bukowski, M., Rosenberger, T.A., Picklo, M.: Quantitation of isobaric 
phosphatidylcholine species in human plasma using a hybrid quadrupole linear ion-
trap mass spectrometer. J. Lipid Res. 57, 2225-2234 (2016) 
31. Ekroos, K.: Lipidomics perspective: From molecular lipidomics to validated clinical 
diagnostics. In: Ekroos K (ed.). Wiley-VCH, Weinheim, (2012) 
32. Martinez-Seara, H., Róg, T., Pasenkiewicz-Gierula, M., Vattulainen, I., Karttunen, 
M., Reigada, R.: Effect of Double Bond Position on Lipid Bilayer Properties:  Insight 
through Atomistic Simulations. J. Phys. Chem. B. 111, 11162-11168 (2007) 
33. Martinez-Seara, H., Róg, T., Pasenkiewicz-Gierula, M., Vattulainen, I., Karttunen, 
M., Reigada, R.: Interplay of Unsaturated Phospholipids and Cholesterol in 
Membranes: Effect of the Double-Bond Position. Biophys. J. 95, 3295-3305 (2008) 
34. Renne, M.F., de Kroon, A.I.P.M.: The role of phospholipid molecular species in 
determining the physical properties of yeast membranes. FEBS Lett. 592, 1330-1345 
(2018) 
35. Ma, X., Chong, L., Tian, R., Shi, R., Hu, T.Y., Ouyang, Z., Xia, Y.: Identification and 
quantitation of lipid C=C location isomers: A shotgun lipidomics approach enabled by 
photochemical reaction. Proc. Natl. Acad. Sci. USA. 113, 2573-2578 (2016) 
23 
 
36. Vriens, K., Christen, S., Parik, S., Broekaert, D., Yoshinaga, K., Talebi, A., Dehairs, 
J., Escalona-Noguero, C., Schmieder, R., Cornfield, T., Charlton, C., Romero-Pérez, 
L., Rossi, M., Rinaldi, G., Orth, M.F., Boon, R., Kerstens, A., Kwan, S.Y., Faubert, 
B., Méndez-Lucas, A., Kopitz, C.C., Chen, T., Fernandez-Garcia, J., Duarte, J.A.G., 
Schmitz, A.A., Steigemann, P., Najimi, M., Hägebarth, A., Van Ginderachter, J.A., 
Sokal, E., Gotoh, N., Wong, K.-K., Verfaillie, C., Derua, R., Munck, S., Yuneva, M., 
Beretta, L., DeBerardinis, R.J., Swinnen, J.V., Hodson, L., Cassiman, D., Verslype, 
C., Christian, S., Grünewald, S., Grünewald, T.G.P., Fendt, S.-M.: Evidence for an 
alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 566, 
403-406 (2019) 
37. Pauling, J.K., Hermansson, M., Hartler, J., Christiansen, K., Gallego, S.F., Peng, B., 
Ahrends, R., Ejsing, C.S.: Proposal for a common nomenclature for fragment ions in 
mass spectra of lipids. PLoS ONE. 12, e0188394 (2017) 
38. Poad, B.L.J., Maccarone, A.T., Yu, H., Mitchell, T.W., Saied, E.M., Arenz, C., 
Hornemann, T., Bull, J.N., Bieske, E.J., Blanksby, S.J.: Differential-Mobility 
Spectrometry of 1-Deoxysphingosine Isomers: New Insights into the Gas Phase 
Structures of Ionized Lipids. Anal. Chem. 90, 5343-5351 (2018) 
39. Groessl, M., Graf, S., Knochenmuss, R.: High resolution ion mobility-mass 
spectrometry for separation and identification of isomeric lipids. Analyst. 140, 6904-
6911 (2015) 
40. Kyle, J.E., Zhang, X., Weitz, K.K., Monroe, M.E., Ibrahim, Y.M., Moore, R.J., Cha, 
J., Sun, X., Lovelace, E.S., Wagoner, J., Polyak, S.J., Metz, T.O., Dey, S.K., Smith, 
R.D., Burnum-Johnson, K.E., Baker, E.S.: Uncovering biologically significant lipid 
isomers with liquid chromatography, ion mobility spectrometry and mass 
spectrometry. Analyst. 141, 1649-1659 (2016) 
41. Ma, X., Xia, Y.: Pinpointing Double Bonds in Lipids by Paternò-Büchi Reactions and 
Mass Spectrometry. Angew. Chem. Int. Ed. 53, 2592-2596 (2014) 
42. Ryan, E., Nguyen, C.Q.N., Shiea, C., Reid, G.E.: Detailed Structural Characterization 
of Sphingolipids via 193 nm Ultraviolet Photodissociation and Ultra High Resolution 
Tandem Mass Spectrometry. J. Am. Soc. Mass Spectrom. 28, 1406-1419 (2017) 
43. Williams, P.E., Klein, D.R., Greer, S.M., Brodbelt, J.S.: Pinpointing double bond and 
sn-positions in glycerophospholipids via hybrid 193 nm ultraviolet photodissociation 
(UVPD) mass spectrometry. J. Am. Chem. Soc. 139, 15681-15690 (2017) 
44. Campbell, J.L., Baba, T.: Near-Complete Structural Characterization of 
Phosphatidylcholines Using Electron Impact Excitation of Ions from Organics. Anal. 
Chem. 87, 5837-5845 (2015) 
45. Yang, K., Dilthey, B.G., Gross, R.W.: Identification and Quantitation of Fatty Acid 
Double Bond Positional Isomers: A Shotgun Lipidomics Approach Using Charge-
Switch Derivatization. Anal. Chem. 85, 9742-9750 (2013) 
46. Wang, M., Han, R.H., Han, X.: Fatty Acidomics: Global Analysis of Lipid Species 
Containing a Carboxyl Group with a Charge-Remote Fragmentation-Assisted 
Approach. Anal. Chem. 85, 9312-9320 (2013) 
47. Ma, X., Zhao, X., Li, J., Zhang, W., Cheng, J.-X., Ouyang, Z., Xia, Y.: Photochemical 
Tagging for Quantitation of Unsaturated Fatty Acids by Mass Spectrometry. Anal. 
Chem. 88, 8931-8935 (2016) 
48. Zhang, W.P., Zhang, D.H., Chen, Q.H., Wu, J.H., Ouyang, Z., Xia, Y.: Online 
photochemical derivatization enables comprehensive mass spectrometric analysis of 
unsaturated phospholipid isomers. Nat. Commun. 10, 79 (2019) 
24 
 
49. Thomas, M.C., Mitchell, T.W., Blanksby, S.J.: Online ozonolysis methods for the 
determination of double bond position in unsaturated lipids. Methods Mol. Biol. 579, 
413-441 (2009) 
50. Thomas, M.C., Mitchell, T.W., Harman, D.G., Deeley, J.M., Nealon, J.R., Blanksby, 
S.J.: Ozone-induced dissociation:  Elucidation of double bond position within mass-
selected lipid ions. Anal. Chem. 80, 303-311 (2008) 
51. Matyash, V., Liebisch, G., Kurzchalia, T.V., Shevchenko, A., Schwudke, D.: Lipid 
extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 
1137-1146 (2008) 
52. Olsen, J.V., Macek, B., Lange, O., Makarov, A., Horning, S., Mann, M.: Higher-
energy C-trap dissociation for peptide modification analysis. Nat. Methods. 4, 709-
712 (2007) 
53. Liebisch, G., Vizcaíno, J.A., Köfeler, H., Trötzmüller, M., Griffiths, W.J., Schmitz, 
G., Spener, F., Wakelam, M.J.O.: Shorthand notation for lipid structures derived from 
mass spectrometry. J. Lipid Res. 54, 1523-1530 (2013) 
54. Fahy, E., Subramaniam, S., Brown, H.A., Glass, C.K., Merrill, A.H., Murphy, R.C., 
Raetz, C.R.H., Russell, D.W., Seyama, Y., Shaw, W., Shimizu, T., Spener, F., van 
Meer, G., VanNieuwenhze, M.S., White, S.H., Witztum, J.L., Dennis, E.A.: A 
comprehensive classification system for lipids. J. Lipid Res. 46, 839-862 (2005) 
55. Yu, Z., Chen, H., Zhu, Y., Ai, J., Li, Y., Gu, W., Borgia, J.A., Zhang, J., Jiang, B., 
Chen, W., Deng, Y.: Global lipidomics reveals two plasma lipids as novel biomarkers 
for the detection of squamous cell lung cancer: A pilot study. Oncol. Lett. 16, 761-768 
(2018) 
56. Hancock, S.E., Maccarone, A.T., Poad, B.L.J., Trevitt, A.J., Mitchell, T.W., 
Blanksby, S.J.: Reaction of ionised steryl esters with ozone in the gas phase. Chem. 
Phys. Lipids. 221, 198-206 (2019) 
57. Ren, J., Franklin, E.T., Xia, Y.: Uncovering Structural Diversity of Unsaturated Fatty 
Acyls in Cholesteryl Esters via Photochemical Reaction and Tandem Mass 
Spectrometry. J. Am. Soc. Mass Spectrom. 28, 1432-1441 (2017) 
58. Poad, B.L.J., Pham, H.T., Thomas, M.C., Nealon, J.R., Campbell, J.L., Mitchell, 
T.W., Blanksby, S.J.: Ozone-Induced Dissociation on a Modified Tandem Linear Ion-
Trap: Observations of Different Reactivity for Isomeric Lipids. J. Am. Soc. Mass 
Spectrom. 21, 1989-1999 (2010) 
59. Barrientos, R.C., Vu, N., Zhang, Q.: Structural Analysis of Unsaturated 
Glycosphingolipids Using Shotgun Ozone-Induced Dissociation Mass Spectrometry. 
J. Am. Soc. Mass Spectrom. 28, 2330-2343 (2017) 
60. Steiner, R., Saied, E.M., Othman, A., Arenz, C., Maccarone, A.T., Poad, B.L.J., 
Blanksby, S.J., von Eckardstein, A., Hornemann, T.: Elucidating the chemical 
structure of native 1-deoxysphingosine. J. Lipid Res. 57, 1194-1203 (2016) 
61. Ryan, E., Reid, G.E.: Chemical Derivatization and Ultrahigh Resolution and Accurate 
Mass Spectrometry Strategies for “Shotgun” Lipidome Analysis. Acc. Chem. Res. 49, 
1596-1604 (2016) 
62. Thomas, M.C., Mitchell, T.W., Harman, D.G., Deeley, J.M., Murphy, R.C., Blanksby, 
S.J.: Elucidation of double bond position in unsaturated lipids by ozone electrospray 
ionization mass spectrometry. Anal. Chem. 79, 5013-5022 (2007) 
63. Bielow, C., Mastrobuoni, G., Orioli, M., Kempa, S.: On Mass Ambiguities in High-
Resolution Shotgun Lipidomics. Anal. Chem. 89, 2986-2994 (2017) 
64. Heiskanen, L.A., Suoniemi, M., Ta, H.X., Tarasov, K., Ekroos, K.: Long-Term 
Performance and Stability of Molecular Shotgun Lipidomic Analysis of Human 
Plasma Samples. Anal. Chem. 85, 8757-8763 (2013)  
25 
 
Table 1: Ozonolysis neutral losses (Da) for monounsaturated FAs 
DB position (n-x) Aldehyde Ion Criegee Ion 
3 26.0520 10.0571 
4 40.0677 24.0728 
6 68.0990 52.1041 
7 82.1146 66.1197 
9 110.1459 94.1510 
10 124.1616 108.1667 
15 194.2398 178.2449 




























































Figure 1: Hierarchical description of the number of unique PC lipids in human plasma. 
Experimental data taken from Zacek et al.[30] The outer circle is a theoretical maximum 
gained from searching the 22 reported PC sum compositions against the Lipid MAPS 
database. 
 
Figure 2: OzID spectra obtained for (A) CE 18:1 (m/z 673.59); (B) CE 18:2 (m/z 671.57); (C) 
CE 18:3 (m/z 669.56); and (D) CE 20:4 (m/z 695.58). The precursor ion in each spectrum is 
indicated by a star while [M+Na+16]
+
 product ions are denoted by closed circles. OzID 
product ions indicative of the positions of unsaturation are indicated with coloured brackets. 
 
Figure 3: The unsaturation profile of complex plasma lipids from a data-independent OzID 
workflow obtained by plotting all precursor ions against product ions. Ions corresponding to 
all lipid carriers of n-6 and n-9 double bonds are indicated by highlighted diagonal lines. 
 
Figure 4: Unsaturation profiles reconstructed from ions exhibiting a common neutral loss 
(indicated in parentheses). Cholesterol esters are not shown in these profiles due to additional 
reaction of the sterol headgroup with ozone. 
 
Figure 5: Compiling all precursor ions exhibiting a common neutral loss characteristic for: 
(A) n-15 or (B) n-17 double bonds generates a profile of all plasmalogens. 
 
Figure 6: Identification of n-9 double bonds in isobaric PC O-34:1 and PE 36:1 lipids 
 
Figure 7: Ozone induced-dissociation mass spectra obtained for (A) PC 34:1 (m/z 782.57); 
(B) PC 34:2 (m/z 780.57). Ozonolysis of phosphatidylcholines identifies multiple double 
bond isomers but does not pinpoint the fatty acyl moiety on which they are located. 
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